CASTRATION-SENSITIVE PROSTATE CARCINOMA
Clinical trials for CASTRATION-SENSITIVE PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-SENSITIVE PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for CASTRATION-SENSITIVE PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Threat drug combo aims to tame aggressive prostate cancer
Disease control OngoingThis study is testing whether a combination of three drugs—apalutamide, abiraterone acetate, and prednisone—can better control advanced prostate cancer that has spread to other parts of the body. The treatment is given to men who have already completed a standard chemotherapy. Th…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Could prostate cancer patients take a break from harsh hormone drugs?
Disease control OngoingThis study is testing whether men with advanced prostate cancer that has spread can safely take a break from hormone-blocking medications when their cancer responds exceptionally well to treatment. The trial involves 79 men who have been on strong hormone therapy for 18-24 months…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC